Endexx Corporation Appoints Ahmed Itani to Director of Marketing of HYLA in The Middle East Region

Former Abbot Laboratories Sales Manager for Middle East and Africa Brings industry Experience to Endexx Corporation

CAVE CREEK, AZ, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, today announced it has appointed Ahmed Itani to lead HYLA’s marketing efforts in The Middle East region.

A seasoned professional with an impressive track record in the corporate world, Itani boasts 14 years of commercial healthcare sales experience and is a dynamic team player who has consistently excelled in driving business growth and fostering strong client relationships.

“Mr. Itani’s wealth of experience, strategic vision, and commitment to success makes him a perfect match to lead HYLA’s marketing efforts in The Middle East,” said Todd Davis, CEO of Endexx Corporation. “We are excited to welcome Mr. Itani and continue to expand the HYLA team as the demand for plant-based products grows throughout the world.”

Mr. Itani’s career began at Abbott Laboratories, where he took charge of managing the commercial activities in The Middle East region. Through meticulous customer relationship management and astute distributor oversight, Itani played a key role in expanding Abbott Laboratories' presence in this vital market.

“Today I am embarking on an exciting new chapter in the ever-evolving industry of alternative vaping,” said Itani, Director of Marketing for HYLA Middle East. “As an integral part of HYLA Holdco USA, I am on a mission to elevate the business to unprecedented heights.”

www.endexx.com & www.cbdunlimited.com 

www.tryhyla.com

About Endexx Corporation

Endexx Corporation develops and distributes all natural, plant-derived wellness products and topical skincare products.  Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness.  The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com

Hyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 10 countries and has signed distribution agreements with an additional nine countries. www.tryhyla.com